Rocket Pharmaceuticals (RCKT) Change in Account Payables (2014 - 2017)

Rocket Pharmaceuticals has disclosed Change in Account Payables across 4 years of filings, most recently posting $68000.0 for Q4 2017.

• Change in Account Payables for Q4 2017 came in at $68000.0, up 136.76% year-over-year; the trailing twelve-month figure through Dec 2017 was -$1.1 million (down 2682.93% YoY), and the FY2017 annual result was -$1.1 million, down 2682.93% from the prior year.
• Change in Account Payables came in at $68000.0 for Q4 2017 at Rocket Pharmaceuticals, up from $15000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $896000.0 in Q3 2015 to a low of -$1.5 million in Q2 2017.
• The 4-year median for Change in Account Payables is $41500.0 (2017), against an average of $13875.0.
• Peak annual rise in Change in Account Payables reached 527.78% in 2015, while the deepest fall reached 393.37% in 2015.
• Rocket Pharmaceuticals' Change in Account Payables stood at $98000.0 in 2014, then tumbled by 177.55% to -$76000.0 in 2015, then tumbled by 143.42% to -$185000.0 in 2016, then jumped by 136.76% to $68000.0 in 2017.
• The last three Change in Account Payables figures came in at $68000.0 (Q4 2017), $15000.0 (Q3 2017), and -$1.5 million (Q2 2017), per Business Quant data.